A Review On Herbal Drug And Drug Interactions

Authors

  • Vallepu Divya, C Priyadarshini Institute of Pharmaceutical Education and Research 5th Mile, Pulladigunta, Guntur-522017. Andhra Pradesh, India.

Keywords:

Herbal drugs, Herbal medicines, Drug Interactions

Abstract

Herbal medicines are increasingly popular worldwide, with an estimated one third of adults in developed nations and over 80% of people in developing countries using them for health promotion and to manage conditions like colds, inflammation, heart disease, diabetes, and central nervous system disorders. Despite their popularity, the mechanisms of action of many herbal medicines remain largely unknown, and their efficacy and toxicity are often inadequately supported by evidence. There are more than 11,000 medicinal plant species, with around 500 commonly used in Asia and other regions. Drug interactions with herbal medicines pose significant safety risks, especially with drugs that have narrow therapeutic windows, such as warfarin and digoxin. Combining herbal remedies with pharmaceuticals can alter their pharmacokinetics and pharmacodynamics, leading to potentially severe adverse reactions. A review of the top-selling herbal medicines, including St. John’s wort, ginkgo, ginseng, garlic, echinacea, saw palmetto, and kava, identified interactions with several prescribed drugs. For example, St. John’s wort lowers blood concentrations of warfarin, while ginkgo increases bleeding risks with warfarin. Ginseng affects alcohol and warfarin levels, and garlic alters the pharmacokinetics of paracetamol and warfarin. It is essential for healthcare providers to be aware of these interactions to avoid serious clinical consequences.

Downloads

Download data is not yet available.

References

Rosser E. On Becoming Professor: A Semi-Serious Look in the Mirror. Fla. St. UL Rev.. 2008;36:215. https://doi.org/10.12678/1089-313X.24.3.126

Goodwin B, Moore LB, Stoltz CM, McKee DD, Kliewer SA. Regulation of the human CYP2B6 gene by the nuclear pregnane X receptor. Molecular pharmacology. 2001 Sep 1;60(3):427-31. https://doi.org/10.1016/S0026-895X(24)12603-X

Perloff MD, Von Moltke LL, Störmer E, Shader RI, Greenblatt DJ. Saint John's wort: an in vitro analysis of P‐glycoprotein induction due to extended exposure. British journal of pharmacology. 2001 Dec;134(8):1601-8.

https://doi.org/10.1038/sj.bjp.0704399

Pj N. Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance. Clin Pharmacol Ther.. 2006;80:565-81.

https://doi.org/10.1016/j.clpt.2006.09.003

Goodwin B, Redinbo MR, Kliewer SA. Regulation of cyp3a gene transcription by the pregnane x receptor. Annual review of pharmacology and toxicology. 2002 Apr;42(1):1-23.

https://doi.org/10.1210/mend.14.1.0409

Rendic S. Summary of information on human CYP enzymes: human P450 metabolism data. Drug metabolism reviews. 2002 Jan 1;34(1-2):83-448. https://doi.org/10.1081/DMR-120001392

Tateishi T, Asoh M, Nakura H, Watanabe M, Tanaka M, Kumai T, Kobayashi S. Carbamazepine induces multiple cytochrome P450 subfamilies in rats. Chemico-biological interactions. 1999 Feb 12;117(3):257-68.

https://doi.org/10.1016/S0009-2797(98)00110-0

Smolinske SC. Dietary supplement-drug interactions. Journal of the American Medical Women's Association (1972). 1999 Jan 1;54(4):191-2. https://doi.org/10.1016/j.ctcp.2006.06.002

Tateishi T, Asoh M, Nakura H, Watanabe M, Tanaka M, Kumai T, Kobayashi S. Carbamazepine induces multiple cytochrome P450 subfamilies in rats. Chemico-biological interactions. 1999 Feb 12;117(3):257-68.

https://doi.org/10.1016/S0009-2797(98)00110-0

Smolinske SC. Dietary supplement-drug interactions. Journal of the American Medical Women's Association (1972). 1999 Jan 1;54(4):191-2. https://doi.org/10.1016/j.ctcp.2006.06.002

McIntyre M. A review of the benefits, adverse events, drug interactions, and safety of St. John's Wort (Hypericum perforatum): The implications with regard to the regulation of herbal medicines. The Journal of Alternative and Complementary Medicine. 2000 Apr 1;6(2):115-24.

https://doi.org/10.1089/acm.2000.6.115

Shaw D, Leon C, Kolev S, Murray V. Traditional remedies and food supplements: a 5-year toxicological study (1991–1995). Drug safety. 1997 Nov;17(5):342-56. https://doi.org/10.5694/j.1326-5377.1997.tb123246.x

lmeida JC, Grimsley EW. Coma from the health food store: interaction between kava and alprazolam. Annals of Internal Medicine. 1996 Dec 1;125(11):940-1. https://doi.org/10.7326/0003-4819-125-11-199612010-00023

Rey JM, Walter G. Hypericum perforatum (St John's wort) in depression: pest or blessing?. Medical journal of Australia. 1998 Dec;169(11-12):583-6. https://doi.org/10.5694/j.1326-5377.1998.tb123424.x

Duche JC, Barre J, Guinot P, Duchier J, Cournot A, Tillement JP. Effect of Ginkgo biloba extract on microsomal enzyme induction. International journal of clinical pharmacology research. 1989 Jan 1;9(3):165-8.

https://doi.org/10.1016/S0024-3205(01)01557-0

Schulz V. Johanniskraut als pflanzliches Antidepressivum. Phytopharmaka in Forschung und klinischer Anwendung. 1995:159-75. https://doi.org/10.1016/S0944-7113(11)80016-4

Rowin J, Lewis SL. Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion. Neurology. 1996 Jun;46(6):17756.

https://doi.org/10.1212/WNL.46.6.1775

Koo MW. Effects of ginseng on ethanol induced sedation in mice. Life sciences. 1998 Dec 4;64(2):153-60.

https://doi.org/10.1016/S0024-3205(98)00545-1

Linde K, Ramirez G, Mulrow CD, Pauls A, Weidenhammer W, Melchart D. St John's wort for depression—an overview and meta-analysis of randomised clinical trials. Bmj. 1996 Aug 3;313(7052):253-8.

https://doi.org/10.1136/bmj.313.7052.253

Stevinson C, Ernst E. Safety of Hypericum in patients with depression: a comparison with conventional antidepressants. CNS drugs. 1999 Feb;11(2):125-3

https://doi.org/10.1016/j.jad.2003.12.017

Godela, R., Nelson, V.K., Nuli, M.V. et al. A new RP-HPLC approach for estimation of potential impurities of Fosamprenavir - method development and validation. BMC Pharmacol Toxicol 26, 60 (2025). https://doi.org/10.1186/s40360-025-00892-5

Awen BZ, Chandu BR, Katakam PR, Dasari VA, Peraman RA. Exploitation of gum olibanum as novel natural binding agenrt in the deigining of oral furosemide formulation. J. Chem. Pharma. Sci. 2010;3:71-4.

https://doi.org/10.1136/oem.59.2.140

Published

2025-07-23

How to Cite

C, V. D. (2025). A Review On Herbal Drug And Drug Interactions . UPI Journal of Chemical and Life Sciences, 8(2), 23–28. Retrieved from https://uniquepubinternational.com/journals/index.php/jcls/article/view/137

Issue

Section

Review Article(s)